Balyasny Asset Management
IMGN

Balyasny Asset Management’s Immunogen Inc IMGN Stock Holding History

Balyasny Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,496,758
Closed -$44.4M – 3257
2023
Q4 		$44.4M Buy
1,496,758
+1,484,838
+12,457% +$29.6M 0.08% 301
2023
Q3 		$189K Sell
11,920
-1,020,659
-99% -$17M ﹤0.01% 2042
2023
Q2 		$19.5M Buy
1,032,579
+929,828
+905% +$11M 0.04% 544
2023
Q1 		$395K Sell
102,751
-284,043
-73% -$1.21M ﹤0.01% 2020
2022
Q4 		$1.92M Buy
+386,794
New +$2.1M 0.01% 1449
2022
Q3 		– Sell
-109,741
Closed -$493K – 3374
2022
Q2 		$493K Buy
+109,741
New +$477K ﹤0.01% 1982
2021
Q3 		– Sell
-191,876
Closed -$1.26M – 2535
2021
Q2 		$1.26M Buy
+191,876
New +$1.34M 0.01% 1180
2019
Q2 		– Sell
-430,328
Closed -$1.17M – 1792
2019
Q1 		$1.17M Buy
430,328
+177,243
+70% +$768K 0.01% 975
2018
Q4 		$1.22M Buy
+253,085
New +$1.54M 0.01% 848
2018
Q2 		– Sell
-68,023
Closed -$716K – 2240
2018
Q1 		$716K Buy
68,023
+43,045
+172% +$425K ﹤0.01% 1340
2017
Q4 		$160K Buy
+24,978
New +$154K ﹤0.01% 1938
2016
Q3 		– Sell
-22,222
Closed -$68K – 1330
2016
Q2 		$68K Buy
+22,222
New +$139K ﹤0.01% 1108

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Balyasny Asset Management's IMGN Position: Q1 2024 in Review

Balyasny Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,496,758 shares — an estimated $44.4M sold.

Balyasny Asset Management first reported a position in IMGN in Q2 2016 and held it in 12 quarters. The position peaked at $44.4M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Balyasny Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 1,496,758 Immunogen Inc shares in Q1 2024, an estimated $44.4M.
  • Balyasny Asset Management first reported a position in Immunogen Inc in Q2 2016 and held it in 12 quarters.
  • Balyasny Asset Management's Immunogen Inc position peaked at $44.4M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Balyasny Asset Management's 13F filing for Q1 2024, filed 13 May 2024.